Dr. Aram Zabeti, MD

Dr. Zabeti practices at UC Medical Center in Cincinnati, Ohio.

Dr. Zabeti's NPI, 1114190014, was assigned on April 11, 2008. Dr. Zabeti holds Ohio license 35.121995.

Dr. Zabeti's primary practice is UC Medical Center, at 3188 Bellevue Ave, Cincinnati, OH 45219 in Hamilton County. The practice phone is (513) 584-1000.

Dr. Zabeti's primary practice is UC Medical Center in Cincinnati, Ohio. Dr. Zabeti is also affiliated with University of Cincinnati Medical Center. The medical group on file is University of Cincinnati Physicians. Dmand AI also links Dr. Zabeti to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zabeti practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Zabeti's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Zabeti is licensed in Ohio.

CMS data shows 188 Medicare services from Dr. Zabeti across 4 procedure codes in 2024, for 97 Medicare patients. Medicare paid $9,197 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 97 Medicare patients who saw Dr. Zabeti in 2024. The largest group is 65 to 74, with 51 patients. 53% of them have high blood pressure, and 47% have high cholesterol. 29% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Zabeti's median patient age at 52, with 73% women.

In 2024, Dr. Zabeti wrote 1,532 Medicare Part D claims for 204 patients. 84% of them were for generic drugs. CMS names the drug for 1,254 of them, across 25 drugs with 11 or more claims each, at $1,726,703 in total drug cost. In 2023, CMS named 1,800 claims across 35 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Zabeti for performance year 2024, reported as part of a group. Dr. Zabeti accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zabeti as offering telehealth.

Dmand AI links 20 papers to Dr. Zabeti, published from 2016 to 2025. 2021 was the busiest year, with 5. The most frequent topics are Multiple Sclerosis, Neuromyelitis Optica and Antibodies, Monoclonal, Humanized. Dr. Zabeti has published most often in Mult Scler Relat Disord. Dr. Zabeti's most frequent co-authors are Pavle Repovic, MD, PhD, Khurram Bashir and Merit Ester Cudkowicz, MD.

Dmand AI links Dr. Zabeti to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Multiple Sclerosis, Relapsing-Remitting and Multiple Sclerosis. Open Payments lists research payments to Dr. Zabeti that name 1 trial.

CMS Open Payments shows 1,600 general payments to Dr. Zabeti from 19 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 72% of the total. Biogen, Inc. paid the most, $462,074. It also lists 13 research payments totaling $3,122 from 2021 to 2024, naming 1 clinical trial.